These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3818966)

  • 21. Evaluation of a nomogram for estimating the rate of phenytoin accumulation.
    Levine M; Orr J; Chang T
    Ther Drug Monit; 1987 Jun; 9(2):166-70. PubMed ID: 3617155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accuracy of Bayesian, Sawchuk-Zaske, and nomogram dosing methods for vancomycin.
    Garrelts JC; Godley PJ; Horton MW; Karboski JA
    Clin Pharm; 1987 Oct; 6(10):795-9. PubMed ID: 3505841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical utility of a new and simple technique for individualizing phenytoin dosage.
    Yukawa E; Higuchi S; Aoyama T
    J Pharmacobiodyn; 1989 Apr; 12(4):187-92. PubMed ID: 2795428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of single-point phenytoin dosage prediction methods in pediatric patients.
    Yukawa E; Higuchi S; Aoyama T
    J Pharmacobiodyn; 1988 Nov; 11(11):736-43. PubMed ID: 3236206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a bayesian pharmacokinetic program for phenytoin concentration predictions in outpatient population.
    Gaulier JM; Boulieu R; Fischer C; Mauguiere
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):295-300. PubMed ID: 9725496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a Bayesian regression-analysis computer program using non-steady-state phenytoin concentrations.
    Godley PJ; Ludden TM; Clementi WA; Godley SE; Ramsey RR
    Clin Pharm; 1987 Aug; 6(8):634-9. PubMed ID: 3691009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new approach to establishing individualized maintenance doses of phenytoin.
    Bachmann K; Sullivan TJ; Schwartz J; Jauregui L
    Ther Drug Monit; 1985; 7(4):391-400. PubMed ID: 4082238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical evaluation of population pharmacokinetic parameters in phenytoin dosage adjustment.
    Yukawa E; Higuchi S; Aoyama T
    Chem Pharm Bull (Tokyo); 1989 Dec; 37(12):3363-6. PubMed ID: 2632085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An updated comparison of drug dosing methods. Part I: Phenytoin.
    Pryka RD; Rodvold KA; Erdman SM
    Clin Pharmacokinet; 1991 Mar; 20(3):209-17. PubMed ID: 1902764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Bayesian graphic method for predicting individual phenytoin dosage schedule.
    Cai WM; Chu XM; Chen G
    Zhongguo Yao Li Xue Bao; 1991 Mar; 12(2):141-4. PubMed ID: 1776478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Individualization of phenytoin dosage regimens.
    Ludden TM; Allen JP; Valutsky WA; Vicuna AV; Nappi JM; Hoffman SF; Wallace JE; Lalka D; McNay JL
    Clin Pharmacol Ther; 1977 Mar; 21(3):287-93. PubMed ID: 837647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic approach to a dosage regimen for phenytoin based on one-point, steady-state plasma concentration.
    Nakashima E; Matsushita R; Kido H; Nakamura M; Asahi M; Ichimura F
    Ther Drug Monit; 1995 Feb; 17(1):12-8. PubMed ID: 7725371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenytoin dosage individualization--five methods compared in the elderly.
    Hudson SA; Farquhar DL; Thompson D; Smith RG
    J Clin Pharm Ther; 1990 Feb; 15(1):25-34. PubMed ID: 2318914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Individualizing phenytoin dosage regimens using a programmable calculator.
    Ng PK
    Am J Hosp Pharm; 1980 Apr; 37(4):529-33. PubMed ID: 7377216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of the convenient and direct numerical analytical method of the pharmacokinetics of phenytoin by an ordinary and/or the Bayesian weighted least-squares method using the program MULTI2(BAYES).
    Fujita T; Koshiro A
    J Pharmacobiodyn; 1989 Dec; 12(12):717-25. PubMed ID: 2635729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of phenytoin dosage in relation to the variability of phenytoin plasma concentration.
    Van der Velde EA; Driessen O
    Br J Clin Pharmacol; 1981 Jan; 11(1):41-52. PubMed ID: 7213507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nomographic estimation of time to reach steady-state serum concentration during phenytoin therapy.
    Vozeh S; Follath F
    Eur J Clin Pharmacol; 1980 Jan; 17(1):33-5. PubMed ID: 7371697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time-Dependent Decline in Serum Phenytoin Concentration With Heightened Convulsive Seizure Risk by Prolonged Administration of Fosphenytoin in Japanese: A Retrospective Study.
    Ohno Y; Niwa T; Hirai K; Suzuki K; Yamada Y; Hayashi Y; Hayashi H; Suzuki A; Itoh Y
    Ther Drug Monit; 2018 Aug; 40(4):507-511. PubMed ID: 29683874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bayesian prediction of serum phenytoin concentration in a simulation study.
    Higuchi S; Yukawa E; Aoyama T
    Chem Pharm Bull (Tokyo); 1988 May; 36(5):1914-8. PubMed ID: 3203427
    [No Abstract]   [Full Text] [Related]  

  • 40. Predicting unbound phenytoin concentrations in patients receiving valproic acid: a comparison of two prediction methods.
    Kerrick JM; Wolff DL; Graves NM
    Ann Pharmacother; 1995 May; 29(5):470-4. PubMed ID: 7655129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.